Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Gou Y, Li Y, Wang Y, Ma H, et al. Breast Cancer (Dove Med Press) 2025;17:1439-1461.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gou Y, Li Y, Wang Y, Ma H, et al. Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer (Dove Med Press) 2025;17:1439-1461.
PMID: 41497890